首頁
Goodwin Biotechnology

11月 2025Goodwin Biotechnology的市場佔有率分析

learn about gbi, a biopharmaceutical cdmo based in florida that aims to eliminate manufacturing risk for companies developing complex biologic therapeutics.

科學與教育 > 生物學

域名goodwinbio.com

成立年份1992

僱員51 - 200

年度營收$15M - $25M

Goodwin Biotechnology

Goodwin Biotechnology（包含公司地區）

goodwinbio.com

查看更多網站流量與參與度資訊

Goodwin Biotechnology截至 11月 2025 的總收入為 15M - 25M

Goodwin Biotechnology 熱門網域產生的總收入

Goodwin Biotechnology 熱門網域 3 年內的總收入

Goodwin Biotechnology 熱門網域的總收入

goodwinbio.com15M - 25M

透過銷售情報查看更多內容

Goodwin Biotechnology的熱門網域總造訪量

了解Goodwin Biotechnology市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Goodwin Biotechnology的熱門網域平均造訪時長

分析Goodwin Biotechnology參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Goodwin Biotechnology的熱門網域平均頁面瀏覽量

了解Goodwin Biotechnology如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Goodwin Biotechnology按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

leinco.com公司名Leinco Technologies, Inc.僱員51 - 200總部美國, 密蘇里州, St. Louis年度營收$2M - $5M訪問總量18K科學與教育 > 生物學

使用的熱門技術Goodwin Biotechnology

这些是Goodwin Biotechnology顶级域名使用的行业网站技术

轉換與分析 (3)

Google Analytics

小工具 (3)

Twemoji

付費廣告 (2)

DoubleClick

音訊視訊媒體 (2)

YouTube

更多技術

7

檢視所有

新聞與訊號來自Goodwin Biotechnology

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Goodwin Biotechnology, Inc. hires Darrin Schellin as Chief Executive Officer.Goodwin Biotechnology, Inc. has appointed Darrin Schellin as Chief Executive Officer and will also serve as a member of the company's board of directors.

新聞Goodwin Biotechnology, Inc. hired Kent Payne as Board of Directors on Aug 19th '19.Goodwin Biotechnology, Inc., a Contract Development and Manufacturing Organization (CDMO) that uniquely meets the contract development and manufacturing needs for today's complex, targeted biopharmaceuticals, announces the appointments of Brandon Price, Ph.D. and Kent Payne, Ph.D. to its Board of Directors.

新聞Goodwin Biotechnology, Inc. hires Gerald Orehostky as vice president, quality and regulatory.Goodwin Biotechnology has appointed Gerald Orehostky as vice president, quality and regulatory.